Nasal sprays support women 'to the top'

Trimel Pharmaceuticals Corporation is developing a new type of nasal sprays, named Tefina, contains the sexual hormones testosterone, used to treat bipolar type "Summit" in women include difficulty achieving orgasm and depression due to the failure of "it".

Tefina medications have been proven safe and effective for the user. In the tests, 253 women in the us, Canada and Australia have been sprayed this drug test with 3 different doses, including one type of placebo.

Volunteers are treated in 84 days. The result, scientists found patients using the drug has the number "up top" average is 2.3 times, while groups using placebo only 1.7 times to experience the sensation of orgasm.

The team said patients using Tefina nasal sprays do not suffer the adverse side effects.

"Female orgasm disorders are common sexual disorder Monday, influential women," said Dr. Sheryl Kingsberg, a member of the Tefina drug development group, said. "Medium 1/5 of the women said they have difficulty ' to the top ' and 1/4 of these admit they suffer from depression."=